Year-over-year, this metric declined by 100.0%, from $28.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Pharma Solutions — CapEx shows an upward trend with a 6.1% CAGR.
High levels suggest growth investment or infrastructure upgrades, while low levels may indicate a focus on cash preservation or a mature asset base.
Reflects the cash outflows for the acquisition or maintenance of long-term physical assets, such as manufacturing facili...
Standard CapEx metric used to assess capital intensity across all industrial sectors.
iff_segment_pharma_solutions_capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.50M | $7.50M | $7.50M | $18.25M | $18.25M | $18.25M | $18.25M | $26.00M | $26.00M | $26.00M | $26.00M | $28.00M | $19.00M | $16.00M | $22.00M | $28.00M | $10.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +143.3% | +0.0% | +0.0% | +0.0% | +42.5% | +0.0% | +0.0% | +0.0% | +7.7% | -32.1% | -15.8% | +37.5% | +27.3% | -64.3% | -100.0% | — | — |
| YoY Change | — | — | — | — | +143.3% | +143.3% | +143.3% | +42.5% | +42.5% | +42.5% | +42.5% | +7.7% | -26.9% | -38.5% | -15.4% | +0.0% | -47.4% | -100.0% | -100.0% | -100.0% |